Bézard, M., Oghina, S., Vitiello, D., Kharoubi, M., Kordeli, E., Galat, A., . . . Damy, T. (2021). Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationBézard, Mélanie, et al. Dexamethasone Is Associated with Early Deaths in Light Chain Amyloidosis Patients with Severe Cardiac Involvement. Public Library of Science (PLoS), 2021.
MLA (8th ed.) CitationBézard, Mélanie, et al. Dexamethasone Is Associated with Early Deaths in Light Chain Amyloidosis Patients with Severe Cardiac Involvement. Public Library of Science (PLoS), 2021.
Warning: These citations may not always be 100% accurate.